Demographics and Clinical Presentation of Study Patients
| . | n = 39 . |
|---|---|
| Demographics | |
| Median age, y (IQR) | 11.1 (5.7–14.5) |
| Female sex, No. (%) | 22 (56) |
| Clinical presentation | |
| Median time between symptom onset and diagnosis, d (IQR) | 2 (1–3) |
| Reported symptoms, No. (%) | |
| Cough | 32 (82) |
| Fever | 26 (67) |
| Nasal discharge | 25 (64) |
| Headache | 22 (56) |
| Sore throat | 14 (36) |
| Shortness of breath | 13 (33) |
| Myalgia | 13 (33) |
| Abdominal pain | 11 (28) |
| Anosmia | 8 (21) |
| Arthralgia | 7 (18) |
| Diarrhea | 7 (18) |
| Fatigue | 5 (13) |
| Rash | 5 (13) |
| Dysgueusia | 4 (10) |
| Nausea | 4 (10) |
| Vomiting | 3 (8) |
| Thoracic pain | 2 (5) |
| Conjunctivitis | 1 (3) |
| Diagnosis, No. (%) | |
| Upper respiratory tract infection | 27 (69) |
| Influenza-like illness | 2 (5) |
| Fever without source | 2 (5) |
| Pneumonia | 2 (5) |
| Obstructive bronchitis | 2 (5) |
| Sepsis-like event | 1 (3) |
| Croup | 1 (3) |
| ALTEs | 1 (3) |
| Asymptomatic | 1 (3) |
| . | n = 39 . |
|---|---|
| Demographics | |
| Median age, y (IQR) | 11.1 (5.7–14.5) |
| Female sex, No. (%) | 22 (56) |
| Clinical presentation | |
| Median time between symptom onset and diagnosis, d (IQR) | 2 (1–3) |
| Reported symptoms, No. (%) | |
| Cough | 32 (82) |
| Fever | 26 (67) |
| Nasal discharge | 25 (64) |
| Headache | 22 (56) |
| Sore throat | 14 (36) |
| Shortness of breath | 13 (33) |
| Myalgia | 13 (33) |
| Abdominal pain | 11 (28) |
| Anosmia | 8 (21) |
| Arthralgia | 7 (18) |
| Diarrhea | 7 (18) |
| Fatigue | 5 (13) |
| Rash | 5 (13) |
| Dysgueusia | 4 (10) |
| Nausea | 4 (10) |
| Vomiting | 3 (8) |
| Thoracic pain | 2 (5) |
| Conjunctivitis | 1 (3) |
| Diagnosis, No. (%) | |
| Upper respiratory tract infection | 27 (69) |
| Influenza-like illness | 2 (5) |
| Fever without source | 2 (5) |
| Pneumonia | 2 (5) |
| Obstructive bronchitis | 2 (5) |
| Sepsis-like event | 1 (3) |
| Croup | 1 (3) |
| ALTEs | 1 (3) |
| Asymptomatic | 1 (3) |
ALTE, apparent life-threatening event.